EKF Diagnostics Holdings PLC Posting of Annual Report & Accounts &Notice of AGM (1956M)
May 07 2020 - 1:00AM
UK Regulatory
TIDMEKF
RNS Number : 1956M
EKF Diagnostics Holdings PLC
07 May 2020
EKF Diagnostics Holdings plc
("EKF" or the "Company")
Posting of Annual Report & Accounts and Notice of AGM
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed
point-of-care business, confirms that the Annual Report and
Accounts for the year ended 31 December 2019 ("2019 Annual Report")
and the Notice of the Annual General Meeting contained therein (the
"Notice of AGM") are available on the Company's website:
https://www.ekfdiagnostics.com/documents-reports.html
The 2019 Annual Report, the Notice of AGM and details voting by
proxy will be posted to shareholders who have not consented to
receive electronic communications today, 7 May 2020.
The AGM is to be held on 10 June 2020 at 11am at the Company's
offices at Avon House, 19 Stanwell Road, Penarth, Cardiff CF64 2EZ
and will consider the Resolutions set out in the Notice of AGM,
including the proposed resolution to declare a final dividend of 1p
per ordinary share to be paid on 1 December 2020 to shareholders on
the register at the close of business on 5 November 2020.
In light of the current UK Government's public health advice in
response to the COVID-19 outbreak, including to limit travel and
public gatherings, and the likelihood that this advice may remain
in place at the time of the AGM, the Company requests that no
Shareholders should plan to attend the AGM in person.
Only two members appointed by the Board will attend in person,
one of whom will Chair the meeting. These Shareholders will
constitute the minimum quorum for the AGM to take place under the
Company's Articles of Association and the requirements of the
Companies Act 2006. The Company is not facilitating any
arrangements for a physical meeting for any Shareholders on this
day (other than the two members referred to above) other than
online or telephonic participation.
Shareholders wishing to vote on any of the matters of business
are urged to do so through completion of their form of proxy, which
can be submitted to the Company's Registrar online. Forms of proxy
should be completed and submitted online in accordance with the
instructions thereon.
The Company will provide a facility for shareholders to join the
AGM either online or telephonically and there will be an
opportunity for shareholders to ask questions. In order to
facilitate the process, the Board would request that Shareholders
register for the meeting and submit questions in advance, before
5pm (BST) on 8 June 2020.
To register for dial-in details and to submit any questions
please contact Walbrook PR via email at ekf@walbrookpr.com or call
+44 (0)20 7933 8787.
Enquiries:
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-Executive Chairman Tel: 029 2071 0570
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer (Nomad & Broker) Tel: 020 7496 3000
Aubrey Powell / George Tzimas / Carlo Spingardi
(Corporate Finance)
Tom Salvesen (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus/ Lianne Cawthorne Mob: 07980 541 893 / 07584 391 303
About EKF Diagnostics Holdings plc ( www.ekfdiagnostics.com
)
EKF is a leading point-of-care diagnostics and central
laboratory assay manufacturer with an estimated 80,000 hemoglobin,
hematocrit, HbA1c, glucose and lactate analyzers in regular use
across more than 100 countries. EKF specializes in developing tests
for use in anemia and diabetes diagnosis and management, as well as
providing a as well as providing Central Laboratory &
Lifesciences services in the area of clinical chemistry, small lab
analysers, contract fermentation, enzyme manufacturing and
specialised contract manufacturing.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ACSAFMMTMTJMTPM
(END) Dow Jones Newswires
May 07, 2020 02:00 ET (06:00 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2024 to May 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From May 2023 to May 2024